Study for children and young adults with juvenile idiopathic arthritis
Clinical and molecular studies of pediatric rheumatic disease: sJIA and lung or drug complications
This study enrolls children and young adults with Juvenile idiopathic arthritis. The purpose of this study is to understand the relationship between biochemical and genetic markers and the way a person's body responds to drugs. We also want to learn more about the development of lung disease in people with systemic juvenile idiopathic arthritis.
This is a one-time study. We will take extra blood at a time when your child is having their routine blood work done. The visit takes place at UBMD< Kaleida, or Oishei Children's Hospital locations in Buffalo, NY.
Understand the relationship of biochemical and genetic markers to adverse drug responses and/or the development of lung disease in systemic juvenile idiopathic arthritis.
-Children and young adults ages 1-21.
-Diagnosed with Juvenile idiopathic arthritis (sJIA) and has lung involvement.
Due to COVID-19, new enrollment in research studies will be greatly limited.
If you are interested in a study, there may be a longer waiting period to receive a response to your inquiry.
View the guidance for research participants for additional information.
Let us know how the study team can reach you.
If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email email@example.com and someone will assist you.